Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in ...

A couple of University of Nebraska professors have launched a startup company with the goal of bringing to market an ...

You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong ...

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

In a challenging market environment, Ideaya Biosciences Inc . (NASDAQ:IDYA) stock has reached its 52-week low, trading at $22 ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manuf ...

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...